June 19, 2018 04:24 AM EDT

Roche bags full control of Foundation Medicine in $2.4B follow-up buyout

Amber Tong

Whatever Foundation Medicine has been doing since Roche threw its weight behind an R&D collaboration three years ago, both partners are liking it. And now …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Roche bags full control of Foundation Medicine in $2.4B follow-up buyout

Amber Tong

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

'Go ahead and do it': Top RFK Jr. deputy dares drugmakers that might pull manufacturing over new price pressure

New CBER chief Prasad is readying 'massive framework' around vaccines, Makary says

The inside story of the six-month sprint to create the first custom CRISPR therapy for one infant’s rare disease

Eli Lilly turns to South Korean RNA editing biotech for hearing loss in deal worth $1.3B

Bristol Myers CEO says America’s biopharma pole position is not guaranteed

Exclusive: Drug compounder Empower was built on risky shortcuts, ex-employees and inspections allege

Roche bags full con­trol of Foun­da­tion Med­i­cine in $2.4B fol­low-up buy­out

Sign up to read this article for free.

more like this

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Roche bags full control of Foundation Medicine in $2.4B follow-up buyout